MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BCAX — Bicara Therapeutics Inc. Common Stock
NasdaqBicara Therapeutics Inc. Common Stock
$17.63
-0.57(-3.13%)
- O
- 18.50
- H
- 18.96
- L
- 17.56
- V
- 751.03K
⏱️ End-of-day dataAs of Oct 2, 2026
BCAX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $32.35M | $96.69M | $17.17M | $43.66M | $46.21M | $48.97M |
| Other Short Term Investments | $21.63M | $31.81M | $11.85M | N/A | N/A | N/A |
| Other Current Assets | $5.16M | $7.25M | $7.21M | $7.79M | $8.69M | $12.82M |
| Total Current Assets | $54.49M | $42.21M | $29.74M | $44.44M | $47.08M | $50.25M |
| Properties | $1.77M | $2.03M | $2.10M | $2.35M | 688,000.00 | 845,000.00 |
| Other Non Current Assets | $6.91M | $6.91M | $7.79M | $6.84M | $6.63M | $6.62M |
| Total Non Current Assets | $8.68M | $8.94M | $12.73M | $9.20M | $7.32M | $7.46M |
| Total Assets | $55.36M | $43.10M | $42.47M | $45.36M | $47.81M | $51.00M |
| Accounts Payable | $7.44M | $7.79M | $3.66M | $2.91M | $2.74M | $4.51M |
| Accrued Expenses | $28.85M | $15.00M | $12.28M | $11.08M | $14.11M | $9.79M |
| Short Term Debt | $1.14M | $1.12M | $1.09M | $1.07M | 591,000.00 | 607,000.00 |
| Pensions | $1.91M | $5.04M | $3.99M | $2.17M | $1.68M | $3.08M |
| Total Current Liabilities | $39.34M | $28.95M | $21.03M | $17.23M | $19.12M | $17.99M |
| Long Term Debt | 301,000.00 | 593,000.00 | 880,000.00 | $1.16M | 0.00 | 131,000.00 |
| Total Non Current Liabilities | 301,000.00 | 593,000.00 | 880,000.00 | $1.16M | 0.00 | 131,000.00 |
| Total Liabilities | $39.64M | $29.54M | $21.91M | $18.39M | $19.12M | $18.12M |
| Common Stock | 8,000.00 | 7,000.00 | 7,000.00 | 7,000.00 | 7,000.00 | 7,000.00 |
| Retained Earnings | $-41.52M | $-35.90M | $-32.16M | $-28.52M | $-25.79M | $-22.10M |
| Other Shareholders Equity | -243,000.00 | 243,000.00 | -136,000.00 | N/A | N/A | N/A |
| Total Shareholders Equity | $51.40M | $40.15M | $40.28M | $43.52M | $45.90M | $49.19M |
| Additional Paid In Capital | $92.94M | $76.02M | $72.45M | $72.04M | $71.68M | $71.29M |
| Investments And Advances | N/A | N/A | $11.74M | N/A | N/A | N/A |